Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.9
Powered by Cell Signaling Technology
Home > Curated Information Page > Cst Curation Set #704
Moritz A (2005) CST Curation Set: 704; Year: 2005; Biosample/Treatment: cell line, K562/-; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XX[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) Akt Substrate Antibody Cat#: 9611
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S2172-p - ACF7 (human) ▲
Modsite: HQPLRNTsFTCQNEQ SwissProt Entrez-Gene
Orthologous residues
ACF7 (human): S2172‑p, ACF7 iso2 (human): ‑, ACF7 iso3 (human): ‑, ACF7 iso5 (human): S607‑p, ACF7 iso6 (human): ‑, ACF7 (mouse): S2164‑p, ACF7 iso4 (mouse): ‑, ACF7 iso7 (mouse): ‑, ACF7 (rat): S2167‑p, ACF7 iso2 (rat): ‑
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T313-p - ATG3 (human) ▲
Modsite: YDYTrHFtM______ SwissProt Entrez-Gene
Orthologous residues
ATG3 (human): T313‑p, ATG3 iso2 (human): ‑, ATG3 (mouse): T313‑p, ATG3 (rat): T313‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S420-p - Bcl-2L13 (human) ▲
Modsite: EINAREEsLVEELsP SwissProt Entrez-Gene
Orthologous residues
Bcl‑2L13 (human): S420‑p, Bcl‑2L13 (mouse): S387‑p, Bcl‑2L13 (rat): ‑
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S301-p - Bcr (human) ▲
Modsite: GPLLRsQstsEQEKR SwissProt Entrez-Gene
Orthologous residues
Bcr (human): S301‑p, Bcr iso2 (human): S301‑p, Bcr (mouse): S303‑p, Bcr (rat): S303‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T523-p - BTN2A1 (human) ▲
Modsite: LTLHRVGtHQsL___ SwissProt Entrez-Gene
Orthologous residues
BTN2A1 (human): T523‑p, BTN2A1 iso1 (human): T524‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S526-p - BTN2A1 (human) ▲
Modsite: HRVGtHQsL______ SwissProt Entrez-Gene
Orthologous residues
BTN2A1 (human): S526‑p, BTN2A1 iso1 (human): C527‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S216-p - CDC25C (human) ▲
Modsite: sGLyRsPsMPENLNR SwissProt Entrez-Gene
Orthologous residues
CDC25C (human): S216‑p, CDC25C iso3 (human): S173‑p, CDC25C (mouse): ‑, CDC25C (frog): S287‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T160-p - CDK2 (human) ▲
Modsite: GVPVRtytHEVVtLW SwissProt Entrez-Gene
Orthologous residues
CDK2 (human): T160‑p, CDK2 iso2 (human): T160‑p, CDK2 (mouse): T160‑p, CDK2 (rat): T160‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1862-p - CENPF (human) ▲
Modsite: ELLQRVEtsEGLNsD SwissProt Entrez-Gene
Orthologous residues
CENPF (human): T1862‑p, CENPF (mouse): R1861‑p, CENPF (rat): R1848‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1863-p - CENPF (human) ▲
Modsite: LLQRVEtsEGLNsDL SwissProt Entrez-Gene
Orthologous residues
CENPF (human): S1863‑p, CENPF (mouse): S1862‑p, CENPF (rat): S1849‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S873-p - CENTG3 (human) ▲
Modsite: AELHRSPsLL_____ SwissProt Entrez-Gene
Orthologous residues
CENTG3 (human): S873‑p, CENTG3 iso2 (human): S874‑p, CENTG3 iso3 (human): ‑, CENTG3 iso4 (human): S909‑p, CENTG3 (mouse): S908‑p, CENTG3 (rat): S536‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S211-p - CLIC1 (human) ▲
Modsite: rGVHRyLsNAyAREE SwissProt Entrez-Gene
Orthologous residues
CLIC1 (human): S211‑p, CLIC1 (mouse): S211‑p, CLIC1 (rat): S211‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S73-p - GAK (human) ▲
Modsite: YALKRLLsNEEEkNR SwissProt Entrez-Gene
Orthologous residues
GAK (human): S73‑p, GAK (mouse): S73‑p, GAK (rat): S73‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T295-p - IFNGR1 (human) ▲
Modsite: IsVVRsAtLEtkPEs SwissProt Entrez-Gene
Orthologous residues
IFNGR1 (human): T295‑p, IFNGR1 (mouse): T302‑p, IFNGR1 (rat): T289‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1076-p - INF2 (human) ▲
Modsite: PRPLERRssWyVDAs SwissProt Entrez-Gene
Orthologous residues
INF2 (human): S1076‑p, INF2 iso2 (human): S1076‑p, INF2 (mouse): S1101‑p, INF2 (rat): S263‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S520-p - Ku70 (human) ▲
Modsite: AMNkRLGsLVDEFkE SwissProt Entrez-Gene
Orthologous residues
Ku70 (human): S520‑p, Ku70 (mouse): S518‑p, Ku70 (rat): S518‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S649-p - LARP5 (human) ▲
Modsite: AtELRkPsyAEICQR SwissProt Entrez-Gene
Orthologous residues
LARP5 (human): S649‑p, LARP5 (mouse): S651‑p, LARP5 (rat): S649‑p, LARP5 (cow): S646‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T542-p - MPRIP (human) ▲
Modsite: RREGRsKtFDWAEFR SwissProt Entrez-Gene
Orthologous residues
MPRIP (human): T542‑p, MPRIP iso2 (human): T542‑p, MPRIP iso3 (human): T504‑p, MPRIP (mouse): T540‑p, MPRIP iso6 (mouse): T504‑p, MPRIP (rat): T545‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1972-p - MYO9B (human) ▲
Modsite: ILIERIQsIKEEKED SwissProt Entrez-Gene
Orthologous residues
MYO9B (human): S1972‑p, MYO9B iso2 (human): S1972‑p, MYO9B (mouse): S1929‑p, MYO9B iso3 (mouse): S1913‑p, MYO9B iso5 (mouse): S1943‑p, MYO9B (rat): S1932‑p, MYO9B (cow): S1974‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S937-p - NFkB-p105 (human) ▲
Modsite: ETsFRkLsFtEsLTS SwissProt Entrez-Gene
Orthologous residues
NFkB‑p105 (human): S937‑p, NFkB‑p105 iso2 (human): S938‑p, NFkB‑p105 (mouse): S940‑p, NFkB‑p105 (rat): S942‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S443-p - PHACTR4 (human) ▲
Modsite: EGsHRAHsLLFENSD SwissProt Entrez-Gene
Orthologous residues
PHACTR4 (human): S443‑p, PHACTR4 iso2 (human): S453‑p, PHACTR4 (mouse): S436‑p, PHACTR4 (rat): S456‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S448-p - PJA1 (human) ▲
Modsite: LEEVREPsLQEEQAS SwissProt Entrez-Gene
Orthologous residues
PJA1 (human): S448‑p, PJA1 (mouse): S382‑p, PJA1 (rat): S210‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T774-p - PKN1 (human) ▲
Modsite: GyGDRtstFCGtPEF SwissProt Entrez-Gene
Orthologous residues
PKN1 (human): T774‑p, PKN1 iso2 (human): T780‑p, PKN1 (mouse): T778‑p, PKN1 (rat): T778‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T816-p - PKN2 (human) ▲
Modsite: GyGDRtstFCGtPEF SwissProt Entrez-Gene
Orthologous residues
PKN2 (human): T816‑p, PKN2 iso2 (human): T800‑p, PKN2 (mouse): T815‑p, PKN2 (rat): T817‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S404-p - PNPLA2 (human) ▲
Modsite: VELRRVQsLPsVPLs SwissProt Entrez-Gene
Orthologous residues
PNPLA2 (human): S404‑p, PNPLA2 iso2 (human): S80‑p, PNPLA2 (mouse): S406‑p, PNPLA2 (rat): S398‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S452-p - PPP1R12C (human) ▲
Modsite: AGLQRsAsssWLEGt SwissProt Entrez-Gene
Orthologous residues
PPP1R12C (human): S452‑p, PPP1R12C iso2 (human): S452‑p, PPP1R12C iso3 (human): S451‑p, PPP1R12C iso4 (human): S452‑p, PPP1R12C iso5 (human): S378‑p, PPP1R12C (mouse): S454‑p, PPP1R12C (rat): S454‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S435-p - PTP-PEST (human) ▲
Modsite: KKLERNLsFEIKKVP SwissProt Entrez-Gene
Orthologous residues
PTP‑PEST (human): S435‑p, PTP‑PEST iso2 (human): S305‑p, PTP‑PEST iso3 (human): S316‑p, PTP‑PEST (mouse): S434‑p, PTP‑PEST (rat): S434‑p, PTP‑PEST (cow): S435‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S29-p - RALBP1 (human) ▲
Modsite: sGLtRtPssEEIsPt SwissProt Entrez-Gene
Orthologous residues
RALBP1 (human): S29‑p, RALBP1 (mouse): S29‑p, RALBP1 (rat): S29‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S125-p - RANBP3 (human) ▲
Modsite: PVKRERtssLtQFPP SwissProt Entrez-Gene
Orthologous residues
RANBP3 (human): S125‑p, RANBP3 iso2 (human): S125‑p, RANBP3 iso3 (human): S57‑p, RANBP3 (mouse): S57‑p, RANBP3 (rat): S57‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1185-p - RPRD2 (human) ▲
Modsite: VGsFRsNsFNSTFEH SwissProt Entrez-Gene
Orthologous residues
RPRD2 (human): S1185‑p, RPRD2 iso2 (human): S1148‑p, RPRD2 iso3 (human): S1159‑p, RPRD2 iso5 (human): ‑, RPRD2 (mouse): S1203‑p, RPRD2 iso2 (mouse): S1159‑p, RPRD2 (rat): ‑, RPRD2 (cow): S1188‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S319-p - SCAMP2 (human) ▲
Modsite: RTFHRAAssAAQGAF SwissProt Entrez-Gene
Orthologous residues
SCAMP2 (human): S319‑p, SCAMP2 (mouse): S319‑p, SCAMP2 (rat): S319‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S35-p - SLC26A2 (human) ▲
Modsite: HLELQREsstDFkQF SwissProt Entrez-Gene
Orthologous residues
SLC26A2 (human): S35‑p, SLC26A2 (mouse): S35‑p, SLC26A2 (rat): S35‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S36-p - SLC26A2 (human) ▲
Modsite: LELQREsstDFkQFE SwissProt Entrez-Gene
Orthologous residues
SLC26A2 (human): S36‑p, SLC26A2 (mouse): G36‑p, SLC26A2 (rat): S36‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T37-p - SLC26A2 (human) ▲
Modsite: ELQREsstDFkQFET SwissProt Entrez-Gene
Orthologous residues
SLC26A2 (human): T37‑p, SLC26A2 (mouse): T37‑p, SLC26A2 (rat): T37‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S37-p - SPTA1 (human) ▲
Modsite: EVLTRYQsFKERVAE SwissProt Entrez-Gene
Orthologous residues
SPTA1 (human): S37‑p, SPTA1 iso2 (human): S37‑p, SPTA1 (mouse): R36‑p, SPTA1 (rat): R36‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S24-p - SQSTM1 (human) ▲
Modsite: AREIRRFsFCCsPEP SwissProt Entrez-Gene
Orthologous residues
SQSTM1 (human): S24‑p, SQSTM1 iso2 (human): ‑, SQSTM1 (mouse): S24‑p, SQSTM1 iso2 (mouse): S24‑p, SQSTM1 (rat): S24‑p, SQSTM1 iso2 (rat): S24‑p, SQSTM1 iso3 (rat): S24‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S28-p - SQSTM1 (human) ▲
Modsite: RRFsFCCsPEPEAEA SwissProt Entrez-Gene
Orthologous residues
SQSTM1 (human): S28‑p, SQSTM1 iso2 (human): ‑, SQSTM1 (mouse): S28‑p, SQSTM1 iso2 (mouse): S28‑p, SQSTM1 (rat): S28‑p, SQSTM1 iso2 (rat): S28‑p, SQSTM1 iso3 (rat): S28‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1213-p - TASOR2 (human) ▲
Modsite: VDSSSAstTLGRQCs SwissProt Entrez-Gene
Orthologous residues
TASOR2 (human): T1213‑p, TASOR2 (mouse): V1206‑p, TASOR2 (rat): V1210‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T256-p - THOC4 (human) ▲
Modsite: AyNARMDts______ SwissProt Entrez-Gene
Orthologous residues
THOC4 (human): T256‑p, THOC4 (mouse): T254‑p, THOC4 (rat): T255‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S184-p - UBE2J1 (human) ▲
Modsite: kELARQIsFkAEVNS SwissProt Entrez-Gene
Orthologous residues
UBE2J1 (human): S184‑p, UBE2J1 (mouse): S184‑p, UBE2J1 (rat): S184‑p, UBE2J1 (cow): S184‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T48-p - VAMP8 (human) ▲
Modsite: LEHLRNktEDLEAts SwissProt Entrez-Gene
Orthologous residues
VAMP8 (human): T48‑p, VAMP8 (mouse): T48‑p, VAMP8 (rat): T47‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T54-p - VAMP8 (human) ▲
Modsite: ktEDLEAtsEHFkTT SwissProt Entrez-Gene
Orthologous residues
VAMP8 (human): T54‑p, VAMP8 (mouse): T54‑p, VAMP8 (rat): T53‑p
Characterization
Methods used to characterize site in vivo:  mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.